ViewPoints Interview: Biogen’s Monica Mann Shares Insight on Plegridy to Treat Multiple Sclerosis
Shots: J&J acquires Auris Health, in allstock transaction for $5.7B as total deal value, including $3.4B upfront in cash and $2.35B milestones. The transaction is expected to close in Q2’19 The focus of the agreement is to advance surgical treatments in connection with digital technologies for the treatment of lung cancer including open, laparoscopic, robotic […]Read More
